Avalon GloboCare Corp. Aktie

Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.